JP Morgan Chase’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.94M | Sell |
127,267
-289,141
| -69% | -$5.12M | ﹤0.01% | 4128 |
|
|
2025
Q4 | $7.79M | Buy |
416,408
+203,304
| +95% | +$3.37M | ﹤0.01% | 2923 |
|
|
2025
Q3 | $3.11M | Buy |
213,104
+93,591
| +78% | +$1.18M | ﹤0.01% | 3750 |
|
|
2025
Q2 | $1.32M | Sell |
119,513
-37,304
| -24% | -$363K | ﹤0.01% | 4216 |
|
|
2025
Q1 | $1.4M | Sell |
156,817
-62,751
| -29% | -$584K | ﹤0.01% | 4117 |
|
|
2024
Q4 | $2.07M | Sell |
219,568
-47,311
| -18% | -$431K | ﹤0.01% | 4135 |
|
|
2024
Q3 | $2.15M | Buy |
266,879
+7,620
| +3% | +$66K | ﹤0.01% | 3951 |
|
|
2024
Q2 | $2.2M | Buy |
259,259
+228,396
| +740% | +$2.06M | ﹤0.01% | 3706 |
|
|
2024
Q1 | $277K | Sell |
30,863
-13,226
| -30% | -$123K | ﹤0.01% | 5158 |
|
|
2023
Q4 | $496K | Sell |
44,089
-3,621
| -8% | -$36.4K | ﹤0.01% | 4799 |
|
|
2023
Q3 | $412K | Sell |
47,710
-3,154
| -6% | -$30.4K | ﹤0.01% | 4596 |
|
|
2023
Q2 | $526K | Sell |
50,864
-161,663
| -76% | -$1.79M | ﹤0.01% | 4457 |
|
|
2023
Q1 | $2.31M | Sell |
212,527
-1,321
| -0.6% | -$14K | ﹤0.01% | 3443 |
|
|
2022
Q4 | $2.4M | Buy |
213,848
+13,735
| +7% | +$144K | ﹤0.01% | 3421 |
|
|
2022
Q3 | $2.03M | Sell |
200,113
-7,242
| -3% | -$67.9K | ﹤0.01% | 3448 |
|
|
2022
Q2 | $1.88M | Buy |
207,355
+34,063
| +20% | +$314K | ﹤0.01% | 3601 |
|
|
2022
Q1 | $1.66M | Sell |
173,292
-31,818
| -16% | -$312K | ﹤0.01% | 3909 |
|
|
2021
Q4 | $2.27M | Sell |
205,110
-28,159
| -12% | -$245K | ﹤0.01% | 3764 |
|
|
2021
Q3 | $1.73M | Buy |
233,269
+197,821
| +558% | +$2.21M | ﹤0.01% | 3905 |
|
|
2021
Q2 | $515K | Buy |
35,448
+6,696
| +23% | +$126K | ﹤0.01% | 4676 |
|
|
2021
Q1 | $587K | Sell |
28,752
-7,763
| -21% | -$148K | ﹤0.01% | 4579 |
|
|
2020
Q4 | $648K | Buy |
36,515
+19,368
| +113% | +$348K | ﹤0.01% | 4224 |
|
|
2020
Q3 | $258K | Buy |
17,147
+1,611
| +10% | +$30.2K | ﹤0.01% | 4251 |
|
|
2020
Q2 | $326K | Sell |
15,536
-306
| -2% | -$7.86K | ﹤0.01% | 4050 |
|
|
2020
Q1 | $366K | Buy |
15,842
+1,460
| +10% | +$36.5K | ﹤0.01% | 3982 |
|
|
2019
Q4 | $372K | Sell |
14,382
-2,950
| -17% | -$57.3K | ﹤0.01% | 4383 |
|
|
2019
Q3 | $337K | Sell |
17,332
-75,151
| -81% | -$1.52M | ﹤0.01% | 4363 |
|
|
2019
Q2 | $1.48M | Sell |
92,483
-107,362
| -54% | -$2.18M | ﹤0.01% | 3586 |
|
|
2019
Q1 | $4.53M | Buy |
199,845
+60,700
| +44% | +$1.54M | ﹤0.01% | 2662 |
|
|
2018
Q4 | $3.56M | Buy |
139,145
+127,240
| +1,069% | +$3.44M | ﹤0.01% | 2835 |
|
|
2018
Q3 | $389K | Buy |
11,905
+3,202
| +37% | +$87.3K | ﹤0.01% | 4398 |
|
|
2018
Q2 | $197K | Sell |
8,703
-1,189
| -12% | -$28.2K | ﹤0.01% | 4565 |
|
|
2018
Q1 | $240K | Sell |
9,892
-289
| -3% | -$7.94K | ﹤0.01% | 4308 |
|
|
2017
Q4 | $284K | Sell |
10,181
-29,313
| -74% | -$867K | ﹤0.01% | 4290 |
|
|
2017
Q3 | $1.37M | Sell |
39,494
-980
| -2% | -$32K | ﹤0.01% | 3356 |
|
|
2017
Q2 | $1.61M | Sell |
40,474
-6,413
| -14% | -$247K | ﹤0.01% | 3174 |
|
|
2017
Q1 | $1.73M | Sell |
46,887
-44,089
| -48% | -$1.41M | ﹤0.01% | 3122 |
|
|
2016
Q4 | $2.9M | Buy |
90,976
+47,476
| +109% | +$1.47M | ﹤0.01% | 2843 |
|
|
2016
Q3 | $1.58M | Buy |
43,500
+43,391
| +39,808% | +$1.21M | ﹤0.01% | 2924 |
|
|
2016
Q2 | $2K | Hold |
109
| – | – | ﹤0.01% | 4612 |
|
|
2016
Q1 | $2K | Sell |
109
-151
| -58% | -$2.47K | ﹤0.01% | 4512 |
|
|
2015
Q4 | $4K | Buy |
+260
| New | +$4.13K | ﹤0.01% | 4397 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
VCM
